← Back
Data updated: Mar 10, 2026
SAPTALIS PHARMS
Infectious DiseaseImmunology
SAPTALIS PHARMS is a specialty pharmaceutical company focused on Infectious Disease, Immunology. Key products include LIKMEZ.
1961
Since
7
Drugs
-
Trials
37
Approved (2yr)
Recent Activity
CYCLOSPORINE 2026-01-21
CYCLOSPORINE 2025-11-28
CLOBETASOL PROPIONATE 2025-11-20
METFORMIN HYDROCHLORIDE 2025-11-10
Manufacturing (CMC)
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE 2025-10-29
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE 2025-09-30
CYCLOSPORINE 2025-09-15
CYCLOSPORINE 2025-08-01
Labeling
CYCLOSPORINE 2025-08-01
Labeling
METFORMIN HYDROCHLORIDE 2025-06-24
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 50%
1 drugs
Immunology 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (4)
Company Info
- First Approval
- 1961-06-23
- Latest
- 2025-02-28
- Applications
- 7